The stock ended with a gain of 1% at Rs 323. Over 321,871 shares changed hands at the counter on the BSE today.
____________________________________________
(Updated at 1038 hrs)
Ranbaxy has soared 2% on receiving an order from the government for supplying Oseltamivir capsules for the treatment of AH1N1 virus (swine flu).
The stock today opened at Rs 322 and slipped to a low of Rs 318.
The scrip however recoverd to touch a high of Rs 327 and is now trading at Rs 325, up around 2% from the previous close. Around 82,550 shares have been traded on the BSE so far.
The company has however not provided any information regarding the size of the order.Oseltamivir is the generic version of the Roche's drug Tamiflu, which has been recommended by the World Health Organisation for the treatment of swine flu.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app